Potron G, N'Guyen P, Pignon B
Laboratoire Central d'Hématologie, CHU Robert-Debré, Reims.
J Mal Vasc. 1996;21(3):126-32.
More than 10 epidemiologic studies have established that a high fibrinogen level is a thrombotic risk factor. The role of fibrinogen in arterial occlusion is multiple : the atheroma plaque involvement in formation thrombus, erythrocyte aggregation, whole blood and plasma viscosity. Fibrinogen level is high during inflammation and increases with ageing and in tobacco addicts. In coronary disease, it is an independent risk factor of prognosis value. In arterial peripheral disease, it is a risk factor of postsurgical reocclusion. After a stroke, a high level of fibrinogen is a sign of severe disease. The dosage of fibrinogen is quite easy but requires a precise calibration. The determination of genetic polymorphism associated with high fibrinogen level is promising. Many circumstances can modify fibrinogen level and are targets for prophylaxis treatments. The influence of genetic factors is still discussed.
超过10项流行病学研究已证实,高纤维蛋白原水平是一种血栓形成危险因素。纤维蛋白原在动脉闭塞中发挥着多重作用:动脉粥样斑块参与血栓形成、红细胞聚集、全血和血浆黏度增加。纤维蛋白原水平在炎症期间升高,并随年龄增长以及在吸烟者中升高。在冠心病中,它是具有预后价值的独立危险因素。在周围动脉疾病中,它是术后再闭塞的危险因素。中风后,高纤维蛋白原水平是病情严重的标志。纤维蛋白原的检测相当容易,但需要精确校准。与高纤维蛋白原水平相关的基因多态性的测定很有前景。许多情况可改变纤维蛋白原水平,是预防性治疗的靶点。遗传因素的影响仍在讨论中。